During the past decade, The Crouch Oak Family Practice conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Crouch Oak Family Practice" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Crouch Oak Family Practice" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Hyperlipidemia" (1 trials), "Leg Ulcer" (1 trials) and "Leg Ulcers Venous" (1 trials). Many other conditions were trialed in "The Crouch Oak Family Practice" in a lesser frequency.

Most popular intervention types in "The Crouch Oak Family Practice" are "Drug" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "geko™ medical device" (1 trials) and "glimepiride" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Crouch Oak Family Practice" are 5 trials for "All" genders.

Currently, there are NaN active trials in "The Crouch Oak Family Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Crouch Oak Family Practice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Crouch Oak Family Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".